Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Signe Wildt

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
The American Journal of Gastroenterology|August 3, 2020
Biochemical Diagnosis of Bile Acid Diarrhea: Prospective Comparison With the 75Seleno-Taurohomocholic Acid TestChristian Borup, Signe Wildt, Jüri Rumessen, et al.
Alimentary Pharmacology & Therapeutics|October 5, 2023
Prospective comparison of diagnostic tests for bile acid diarrhoeaChristian Borup, Lars Vinter-Jensen, Søren Peter German Jørgensen, et al.
Eclinicalmedicine|March 11, 2022
Low-dose azathioprine and allopurinol versus azathioprine monotherapy in patients with ulcerative colitis (AAUC): An investigator-initiated, open, multicenter, parallel-arm, randomised controlled trialMarianne Kiszka-Kanowitz, Klaus Theede, Sandra Bohn Thomsen, et al.
Alimentary Pharmacology & Therapeutics|September 2, 2021
Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones: a prospective multicentre population-based cohort studyMette Julsgaard, Daniel C Baumgart, Simon M D Baunwall, et al.
Journal of Crohn'S & Colitis|January 12, 2021
Course of Disease in Patients with Microscopic Colitis: A European Prospective Incident Cohort StudyBas P M Verhaegh, Andreas Münch, Danila Guagnozzi, et al.
Scandinavian Journal of Gastroenterology|July 5, 2021
Vedolizumab as first-line biological therapy in elderly patients and those with contraindications for anti-TNF therapy: a real-world, nationwide cohort of patients with inflammatory bowel diseasesMohamed Attauabi, Camilla Höglund, Janne Fassov, et al.
Gastroenterology|April 12, 2016
Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on InfectionMette Julsgaard, Lisbet A Christensen, Peter R Gibson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 26, 2024
Infant Ustekinumab Clearance, Risk of Infection, and Development After Exposure During PregnancyMette Julsgaard, Jantien W Wieringa, Simon M D Baunwall, et al.
United European Gastroenterology Journal|February 23, 2021
European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendationsStephan Miehlke, Danila Guagnozzi, Yamile Zabana, et al.
Inflammatory Bowel Diseases|May 30, 2019
Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth OutcomesMette Julsgaard, Christian L Hvas, Richard B Gearry, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
The American Journal of Gastroenterology|August 3, 2020
Biochemical Diagnosis of Bile Acid Diarrhea: Prospective Comparison With the 75Seleno-Taurohomocholic Acid TestChristian Borup, Signe Wildt, Jüri Rumessen, et al.
Alimentary Pharmacology & Therapeutics|October 5, 2023
Prospective comparison of diagnostic tests for bile acid diarrhoeaChristian Borup, Lars Vinter-Jensen, Søren Peter German Jørgensen, et al.
Eclinicalmedicine|March 11, 2022
Low-dose azathioprine and allopurinol versus azathioprine monotherapy in patients with ulcerative colitis (AAUC): An investigator-initiated, open, multicenter, parallel-arm, randomised controlled trialMarianne Kiszka-Kanowitz, Klaus Theede, Sandra Bohn Thomsen, et al.
Alimentary Pharmacology & Therapeutics|September 2, 2021
Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones: a prospective multicentre population-based cohort studyMette Julsgaard, Daniel C Baumgart, Simon M D Baunwall, et al.
Journal of Crohn'S & Colitis|January 12, 2021
Course of Disease in Patients with Microscopic Colitis: A European Prospective Incident Cohort StudyBas P M Verhaegh, Andreas Münch, Danila Guagnozzi, et al.
Scandinavian Journal of Gastroenterology|July 5, 2021
Vedolizumab as first-line biological therapy in elderly patients and those with contraindications for anti-TNF therapy: a real-world, nationwide cohort of patients with inflammatory bowel diseasesMohamed Attauabi, Camilla Höglund, Janne Fassov, et al.
Gastroenterology|April 12, 2016
Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on InfectionMette Julsgaard, Lisbet A Christensen, Peter R Gibson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 26, 2024
Infant Ustekinumab Clearance, Risk of Infection, and Development After Exposure During PregnancyMette Julsgaard, Jantien W Wieringa, Simon M D Baunwall, et al.
United European Gastroenterology Journal|February 23, 2021
European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendationsStephan Miehlke, Danila Guagnozzi, Yamile Zabana, et al.
Inflammatory Bowel Diseases|May 30, 2019
Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth OutcomesMette Julsgaard, Christian L Hvas, Richard B Gearry, et al.
Pageof 5